SCHEMBL469951

SCHEMBL469951

Cc1cc(-c2cnc3c(NCC4CCOC4)cc(Oc4cccc(F)c4)nn23)ccc1C(=O)NC1CC1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.73
CYP3A4 P08684 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL470289 0.96 TTK (0.77) TTKCYP3A4
SCHEMBL15556532 0.95 TTK (0.80) TTKCYP3A4
SCHEMBL455615 0.90 TTK (0.68) TTKCYP3A4
SCHEMBL459325 0.90 TTK (0.68) TTKCYP3A4
SCHEMBL459033 0.90 TTK (0.72) TTKCYP3A4
SCHEMBL10279714 0.90 TTK (0.67) TTKCYP3A4
SCHEMBL17590102 0.89 TTK (0.66) TTKCYP3A4
SCHEMBL455433 0.89 TTK (0.66) TTKCYP3A4
SCHEMBL17416392 0.89 TTK (0.68) TTKCYP3A4
SCHEMBL12468434 0.89 TTK (0.66) TTKCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP claimed
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed